Dr. Elmunzer reviewing information with another physician

Member Directory

Center Member Department Research Description
Peggi M. Angel, Ph.D. Cell and Molecular Pharmacology and Experimental Therapeutics MS-analysis of extracellular matrix in liver disease
Tim Barnoud, Ph.D. Biochemistry and Molecular Biology
Heat shock proteins and p53 variants in cancer risk
Heather S. Bonilha, Ph.D., CCC-SLP Health Science & Research Upper GI tract dysfunction
Katherine E. Chetta, M.D. Pediatrics HAMLET and oleic acid in preterm intestinal disease
Richard R. Drake, Ph.D. Cell & Molecular Pharmacology MS approaches for glycan and glycoprotein markers of GI disease
Stephen A. Duncan, DPhil Regenerative Medicine & Cell Biology iPSC hepatocyte modeling of metabolic liver disease
Badih J. Elmunzer, M.D., MSc Medicine GI endoscopy, ERCP, colorectal cancer screening
Amy C. Engevik, Ph.D. Regenerative Medicine & Cell Biology  Microvillus Inclusion Disease (MVID) and cholestasis
Mindy A. Engevik, Ph.D. Regenerative Medicine & Cell Biology  Microbial-host crosstalk in the intestinal mucus layer
Hermes Florez, MD-PhD, MPH Public Health Sciences Aging, metabolism and chronic disease
Marvella Elizabeth Ford Ph.D. Public Health Sciences Disparities in GI cancer diagnosis and treatment
Lewis J. Frey, Ph.D. Public Health Sciences Artificial Intelligence approaches for modeling liver disease
Wenjian Gan, Ph.D. Biochemistry and Molecular Biology Kinase pathways in liver disease and cancer
Gary S. Gilkeson, M.D. Medicine GI and liver disease in SLE
Silvia Guglietta, Ph.D. Microbiology and Immunology Complement factor impact on immune response and gut microbiota in IBD
Denis C. Guttridge, Ph.D. Pediatrics Pancreatic cancer and cachexia
Jessica H. Hartman, Ph.D. Biochemistry and Molecular Biology Metabolism and xenobiotic and mechanistic toxicology in liver disease
Yan Huang, M.D., Ph.D. Medicine Inflammation in periodontal and liver disease
Antonis Kourtidis, Ph.D. Regenerative Medicine & Cell Biology RNAi regulation at colonic epithelial cell junctions
John J. Lemasters, M.D., Ph.D. Drug Discovery & Biomedical Sciences Mitochondria in ethanol and drug-induced liver injury
Eduardo N. Maldonado, DVM, Ph.D. Drug Discovery & Biomedical Sciences Mitochondrial anion channels in liver disease and cancer
Anand S. Mehta, Ph.D. Cell & Molecular Pharmacology Glycoproteomics in liver cancer
Eric G. Meissner, M.D., Ph.D. Medicine Hepatitis C viral infection
Jorge Múnera, Ph.D. Regenerative Medicine and Cell Biology iPSC colonic organoids for modeling GI disease
Satish N. Nadig, M.D., Ph.D. Microbiology & Immunology Immunotherapeutics for liver transplant
Anna-Liisa Nieminen, Ph.D. Drug Discovery & Biomedical Sciences Iron homeostasis and liver injury
Paul J. Nietert, Ph.D. Public Health Sciences Hierarchical data analysis, truncated distributions, randomization in clinical trials
Chad M. Novince, Ph.D., DDS Oral Health Sciences Immunomodulation by the gut microbiome
Jihad S. Obeid, M.D., FAMIA  Public Health Sciences Artificial Intelligence for the early detection of cirrhosis
John P. O'Bryan, Ph.D. Cellular and Molecular Pharmacology Therapeutics targeting RAS function in GI cancer
Don C. Rockey, M.D. Medicine Liver fibrosis and portal hypertension
Andrew D. Schreiner, MD, MSCR  Medicine EHR-based primary care management of chronic liver disease
Stephen Tomlinson, Ph.D. Microbiology & Immunology Complement function in liver damage and regeneration
Özlem Yilmaz, DDS, Ph.D. Oral Health Sciences Oral mucosal infection and cancer and chronic disease
Je-Hyun Yoon, Ph.D. Biochemistry and Molecular Biology RNA signaling in alcoholic gut and liver disease
Hongjun Wang, Ph.D. Surgery Novel therapeutics for chronic pancreatitis
Caroline Westwater, Ph.D. Microbiology & Immunology Candida infections in GI disease
Zhi Zhong, M.D., Ph.D. Drug Discovery & Biomedical Sciences Targeting mitochondrial dysfunction in liver disease